Vir Biotechnology Inc (VIR)
6.965
+0.22
(+3.34%)
USD |
NASDAQ |
Nov 21, 16:00
6.965
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology Price to Book Value: 0.7731 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 0.7481 |
| November 19, 2024 | 0.7692 |
| November 18, 2024 | 0.7803 |
| November 15, 2024 | 0.8891 |
| November 14, 2024 | 0.959 |
| November 13, 2024 | 0.9968 |
| November 12, 2024 | 1.027 |
| November 11, 2024 | 1.096 |
| November 08, 2024 | 1.066 |
| November 07, 2024 | 1.084 |
| November 06, 2024 | 1.129 |
| November 05, 2024 | 1.07 |
| November 04, 2024 | 1.040 |
| November 01, 2024 | 1.028 |
| October 31, 2024 | 0.8314 |
| October 30, 2024 | 0.8436 |
| October 29, 2024 | 0.8447 |
| October 28, 2024 | 0.8602 |
| October 25, 2024 | 0.8303 |
| October 24, 2024 | 0.8098 |
| October 23, 2024 | 0.8286 |
| October 22, 2024 | 0.8385 |
| October 21, 2024 | 0.8429 |
| October 18, 2024 | 0.8407 |
| October 17, 2024 | 0.8506 |
| Date | Value |
|---|---|
| October 16, 2024 | 0.8671 |
| October 15, 2024 | 0.8539 |
| October 14, 2024 | 0.8451 |
| October 11, 2024 | 0.8363 |
| October 10, 2024 | 0.8087 |
| October 09, 2024 | 0.8076 |
| October 08, 2024 | 0.8065 |
| October 07, 2024 | 0.8154 |
| October 04, 2024 | 0.8528 |
| October 03, 2024 | 0.8076 |
| October 02, 2024 | 0.8462 |
| October 01, 2024 | 0.833 |
| September 30, 2024 | 0.8253 |
| September 27, 2024 | 0.7177 |
| September 26, 2024 | 0.6957 |
| September 25, 2024 | 0.6919 |
| September 24, 2024 | 0.7186 |
| September 23, 2024 | 0.7243 |
| September 20, 2024 | 0.7396 |
| September 19, 2024 | 0.7567 |
| September 18, 2024 | 0.7434 |
| September 17, 2024 | 0.7558 |
| September 16, 2024 | 0.7501 |
| September 13, 2024 | 0.7729 |
| September 12, 2024 | 0.7491 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6232
Minimum
Oct 27 2023
15.29
Maximum
Feb 27 2020
4.059
Average
1.814
Median
Jun 05 2023
Price to Book Value Benchmarks
| Pfizer Inc | 1.543 |
| Biomarin Pharmaceutical Inc | 2.233 |
| Arbutus Biopharma Corp | 6.134 |
| GlycoMimetics Inc | 1.821 |
| FibroGen Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 15.24 |
| Price | 6.965 |
| Earnings Yield | -56.28% |
| Market Cap | 959.22M |